Early research (Phase 1)Study completedNCT00002138
What this trial is testing
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.
Who this might be right for
Sarcoma, KaposiHIV Infections
Daiichi Pharmaceuticals